Croda to acquire the maker of biobased ceramides Solus Biotech for US$275 million [Registered]

The speciality chemical firm Croda International has agreed to acquire Solus Biotech, a global leader in premium, biotechnology-derived beauty actives, from Solus Advanced Materials for a total consideration of KRW350 billion (US$275 million) on a debt-free, cash-free basis.… Login to continue